• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乏脂性肾血管平滑肌脂肪瘤在 68Ga-FAPI-04 PET/CT 上模拟肾细胞癌。

Lipid-Poor Renal Angiomyolipoma Mimicking Renal Cell Carcinoma on 68 Ga-FAPI-04 PET/CT.

机构信息

From the Department of Nuclear Medicine, the First Affiliated Hospital of Navy Medical University (Changhai Hospital).

Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine.

出版信息

Clin Nucl Med. 2022 Nov 1;47(11):991-993. doi: 10.1097/RLU.0000000000004297. Epub 2022 May 27.

DOI:10.1097/RLU.0000000000004297
PMID:35619202
Abstract

FAPI PET/CT findings of renal tumors have been rarely reported. We describe 68 Ga-FAPI-04 PET/CT findings in 1 case with lipid-poor renal angiomyolipoma and 1 case with high-grade clear cell renal cell carcinoma. Both tumors showed intense 68 Ga-FAPI-04 uptake. These 2 cases indicate that lipid-poor renal angiomyolipoma should be included in the differential diagnosis of FAPI-avid renal tumors.

摘要

乏脂型肾血管平滑肌脂肪瘤和高级别透明细胞肾细胞癌的 Ga-FAPI-04 PET/CT 表现 乏脂型肾血管平滑肌脂肪瘤和高级别透明细胞肾细胞癌 Ga-FAPI-04 摄取明显。这两例提示乏脂型肾血管平滑肌脂肪瘤应纳入 FAPI 摄取性肾肿瘤的鉴别诊断。

我们描述了 68Ga-FAPI-04 PET/CT 在 1 例乏脂型肾血管平滑肌脂肪瘤和 1 例高级别透明细胞肾细胞癌中的表现。

相似文献

1
Lipid-Poor Renal Angiomyolipoma Mimicking Renal Cell Carcinoma on 68 Ga-FAPI-04 PET/CT.乏脂性肾血管平滑肌脂肪瘤在 68Ga-FAPI-04 PET/CT 上模拟肾细胞癌。
Clin Nucl Med. 2022 Nov 1;47(11):991-993. doi: 10.1097/RLU.0000000000004297. Epub 2022 May 27.
2
68 Ga-FAPI-04 PET/CT in a Small Sarcomatoid Renal Cell Carcinoma With Widespread Metastases.68 Ga-FAPI-04 PET/CT在一例伴有广泛转移的小肉瘤样肾细胞癌中的应用
Clin Nucl Med. 2023 May 1;48(5):457-459. doi: 10.1097/RLU.0000000000004607. Epub 2023 Feb 17.
3
68 Ga-FAPI-04 PET/CT and 18 F-FDG PET/CT in Metastatic Papillary Renal Cell Cancer.68 Ga-FAPI-04 PET/CT与18 F-FDG PET/CT在转移性乳头状肾细胞癌中的应用
Clin Nucl Med. 2023 May 1;48(5):e223-e224. doi: 10.1097/RLU.0000000000004587. Epub 2023 Feb 8.
4
68Ga-FAPI-04 PET/CT in Solitary Choroid Plexus Metastasis From Renal Cell Carcinoma.68Ga-FAPI-04 PET/CT 于肾脏细胞癌孤立性脉络丛转移中的应用。
Clin Nucl Med. 2022 Oct 1;47(10):885-887. doi: 10.1097/RLU.0000000000004207. Epub 2022 Apr 27.
5
68 Ga-FAPI-04 PET/MRI in a Case of Tuberous Sclerosis Complex With Extrarenal Retroperitoneal Angiomyolipoma.68Ga-FAPI-04 PET/MRI 在 1 例伴发肾外腹膜后血管平滑肌脂肪瘤的结节性硬化症中的应用。
Clin Nucl Med. 2023 Aug 1;48(8):729-731. doi: 10.1097/RLU.0000000000004737. Epub 2023 Jun 6.
6
Feasibility of [Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma.[Ga]Ga-FAPI-46 PET/CT 探测高级别尿路上皮癌淋巴结和血行转移的可行性。
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3571-3580. doi: 10.1007/s00259-022-05761-5. Epub 2022 Mar 24.
7
[Causes of False-Positive Results in Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT Imaging].[镓标记的成纤维细胞活化蛋白抑制剂PET/CT成像中假阳性结果的原因]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2023 Jun;45(3):440-444. doi: 10.3881/j.issn.1000-503X.15221.
8
18 F-FDG and 68 Ga-FAPI-04 in the Evaluation of Aggressive Perivascular Epithelioid Cell Tumor.18 F-FDG 和 68 Ga-FAPI-04 评估侵袭性血管外皮细胞瘤。
Clin Nucl Med. 2022 Oct 1;47(10):897-899. doi: 10.1097/RLU.0000000000004249. Epub 2022 Apr 29.
9
Increased 18F-ALF-NOTA-FAPI and 18F-FDG Uptake in Renal Angiomyolipoma.肾血管平滑肌脂肪瘤中 18F-ALF-NOTA-FAPI 和 18F-FDG 的摄取增加。
Clin Nucl Med. 2022 Mar 1;47(3):e306-e310. doi: 10.1097/RLU.0000000000004022.
10
68 Ga-FAPI-04 Versus 18 F-FDG PET/CT in Detection of Epithelioid Malignant Pleural Mesothelioma.68Ga-FAPI-04 与 18F-FDG PET/CT 检测上皮样恶性胸膜间皮瘤的比较。
Clin Nucl Med. 2022 Nov 1;47(11):980-981. doi: 10.1097/RLU.0000000000004269. Epub 2022 May 12.

引用本文的文献

1
Novel radiopharmaceuticals for molecular imaging of renal cell carcinoma.用于肾细胞癌分子成像的新型放射性药物。
BMJ Oncol. 2025 Aug 17;4(1):e000645. doi: 10.1136/bmjonc-2024-000645. eCollection 2025.
2
Performance of [Ga]Ga-FAPI-04 PET/CT imaging in hepatic vascular-associated mesenchymal tumor: comparison with [F]FDG PET/CT.[镓]Ga-FAPI-04 PET/CT成像在肝血管相关间充质瘤中的表现:与[氟]FDG PET/CT的比较
Eur J Nucl Med Mol Imaging. 2025 Jul 24. doi: 10.1007/s00259-025-07446-1.
3
Comparative study of [F]AlF-NOTA-FAPI-RGD and [F]FDG/[F]AlF-NOTA-FAPI-04 PET/CT in renal cell carcinoma.
[F]AlF-NOTA-FAPI-RGD与[F]FDG/[F]AlF-NOTA-FAPI-04 PET/CT在肾细胞癌中的对比研究
Theranostics. 2025 Apr 21;15(12):5790-5800. doi: 10.7150/thno.113070. eCollection 2025.
4
An Atlas of Gallium-68-fibroblast Activation Protein Inhibitor (FAPI) in Oncology and Nononcology Imaging.《镓-68-成纤维细胞活化蛋白抑制剂(FAPI)在肿瘤学和非肿瘤学成像中的图谱》
Indian J Nucl Med. 2024 Sep-Oct;39(5):360-369. doi: 10.4103/ijnm.ijnm_70_24. Epub 2025 Jan 25.
5
A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma.[68Ga]Ga-成纤维细胞激活蛋白抑制剂-04 PET/CT 在肾细胞癌中的初步研究。
Br J Radiol. 2024 Mar 28;97(1156):859-867. doi: 10.1093/bjr/tqae025.
6
The role of [ Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study.镓[68Ga]Ga-FAPI-04 PET/CT 在肾细胞癌中的作用:一项初步研究。
Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):852-861. doi: 10.1007/s00259-023-06461-4. Epub 2023 Oct 7.
7
[Ga]Ga‑LNC1007 PET/CT in the evaluation of renal cell carcinoma: comparison with 2-[F]FDG/[Ga]Ga-PSMA PET/CT.[镓]镓‑LNC1007 PET/CT 在肾细胞癌评估中的应用:与 2-[F]FDG/[镓]镓-PSMA PET/CT 的比较。
Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):535-547. doi: 10.1007/s00259-023-06436-5. Epub 2023 Sep 20.